Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - FREE CASH FLOW
Free Cash Flow YMAB - Y-mAbs Therapeutics, Inc.
-27.2 M
LAST VALUE
48.71%
2 YEAR CAGR
8.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR